Clinical trial
A Phase 1b Study of TAK-659 in Combination With NKTR-214 in Patients With Advanced Non-Hodgkin Lymphoma
NCT03772288 is registered in ClinicalTrials.gov with Calithera Biosciences, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1b Study of TAK-659 in Combination With NKTR-214 in Patients With Advanced Non-Hodgkin Lymphoma
- Lead sponsor
- Calithera Biosciences, Inc
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- April 3, 2019
- Completion date
- November 17, 2021
- Enrollment
- 0 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.